Retraction Note to: Cell Death and Disease https://doi.org/10.1038/s41419-020-03123-3, published online 23 October 2020
The Editor-in-Chief has retracted this article. An investigation by the National Natural Science Foundation of China Supervision Committee confirmed multiple overlaps in figures between different publications and found these images came from a third party provider. Specifically, two panels from Fig. 2H were found to overlap with three panels from Fig. 5D from another article by different authors [1], Fig. 4D from [2], and Fig. 2K from [3]. Figure 7D was found to overlap with Fig. 6D from [4]. All articles were under consideration at the same time. The Editor has lost confidence in the data and conclusions of this article.
The authors have not responded to correspondence from the publisher regarding this retraction.
References
Han S, Zhen W, Guo T, Zou J, Li F. SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway. J Exp Clin Cancer Res. 2020;39:218. https://doi.org/10.1186/s13046-020-01730-8. Retraction in: J Exp Clin Cancer Res. 2022;41:280. https://doi.org/10.1186/s13046-022-02495-y.
Tian T, Guo T, Zhen W, Zou J, Li F. BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells. Cell Death Dis. 2020;11:900. https://doi.org/10.1038/s41419-020-03117-1.
Chen Z, Chen G, Zhao H. FDPS promotes glioma growth and macrophage recruitment by regulating CCL20 via Wnt/β‐catenin signalling pathway. J Cell Mol Med. 2020;24:9055–66.
Wang Z, Zhao Y, Xu H, Liang F, Zou Q, Wang C, Jiang J, Lin F. CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer. J Cell Mol Med. 2020;24:11445–56. https://doi.org/10.1111/jcmm.15751. Erratum in: J Cell Mol Med. 2024;28:e18189. https://doi.org/10.1111/jcmm.18189.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, Z., Tan, X., Luo, J. et al. Retraction Note: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. Cell Death Dis 16, 162 (2025). https://doi.org/10.1038/s41419-025-07492-5
Published:
DOI: https://doi.org/10.1038/s41419-025-07492-5
